Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Characterization and preclinical evaluation of the cGMP grade DNA based vaccine, AV-1959D to enter the first-in-human clinical trials
Irina Petrushina, Armine Hovakimyan, Indira S. Harahap-Carrillo, et al.
Neurobiology of Disease (2020) Vol. 139, pp. 104823-104823
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Amyloid β-based therapy for Alzheimer’s disease: challenges, successes and future
Yun Zhang, Huaqiu Chen, Ran Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 358
Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer’s disease: a systematic review
Danko Jeremic, Lydia Jiménez‐Díaz, Juan D. Navarro‐López
Ageing Research Reviews (2021) Vol. 72, pp. 101496-101496
Open Access | Times Cited: 219
Anti-Amyloid Immunotherapies for Alzheimer's Disease: A 2023 Clinical Update
Golnaz Yadollahikhales, Julio C. Rojas
Neurotherapeutics (2023) Vol. 20, Iss. 4, pp. 914-931
Open Access | Times Cited: 88
Targeting aging and age-related diseases with vaccines
R. H. Wu, Fei Sun, Weiqi Zhang, et al.
Nature Aging (2024) Vol. 4, Iss. 4, pp. 464-482
Closed Access | Times Cited: 25
Microglial activation states and their implications for Alzheimer's Disease
Zachary Valiukas, Kathy Tangalakis, Vasso Apostolopoulos, et al.
The Journal of Prevention of Alzheimer s Disease (2025) Vol. 12, Iss. 1, pp. 100013-100013
Open Access | Times Cited: 4
Immunotherapies for Alzheimer’s Disease—A Review
Zachary Valiukas, Ramya Ephraim, Kathy Tangalakis, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1527-1527
Open Access | Times Cited: 33
Amyloid Precursor Protein: A Regulatory Hub in Alzheimer's Disease
Jiang Chen, Junsheng Chen, Song Li, et al.
Aging and Disease (2023)
Open Access | Times Cited: 18
Alzheimer’s Disease Immunotherapy: Current Strategies and Future Prospects
Ali Aljassabi, Tarek Zieneldien, Janice Kim, et al.
Journal of Alzheimer s Disease (2024) Vol. 98, Iss. 3, pp. 755-772
Closed Access | Times Cited: 6
Vaccines for Alzheimer's disease: a brief scoping review
Ibrahim Serag, Mohamed Abouzid, Mostafa Hossam El Din Moawad, et al.
Neurological Sciences (2025)
Closed Access
Lipid nanoparticle (LNP) mediated mRNA delivery in neurodegenerative diseases
Seyedeh Ghazal Moosavi, Niloufar Rahiman, Mahmoud Reza Jaafari, et al.
Journal of Controlled Release (2025), pp. 113641-113641
Closed Access
Cerebral proteome adaptations to amyloid angiopathy are prevented by carbonic anhydrase inhibitors
Jasper Carlsen, Silvia Fossati, Leif Østergaard, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 4
Open Access
Neuroimaging of Mouse Models of Alzheimer’s Disease
Amandine Jullienne, Michelle V. Trinh, André Obenaus
Biomedicines (2022) Vol. 10, Iss. 2, pp. 305-305
Open Access | Times Cited: 17
mRNA Vaccine for Alzheimer’s Disease: Pilot Study
Armine Hovakimyan, Garri Chilingaryan, Olga King, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 659-659
Open Access | Times Cited: 3
Mechanistic Approach to Immunity and Immunotherapy of Alzheimer’s Disease: A Review
Md. Rubiath Islam, Md. Afser Rabbi, Tanbir Hossain, et al.
ACS Chemical Neuroscience (2024)
Closed Access | Times Cited: 3
Evaluation of chronic lead effects in the blood brain barrier system by DCE-CT
Huiying Gu, Paul R. Territo, Scott A. Persohn, et al.
Journal of Trace Elements in Medicine and Biology (2020) Vol. 62, pp. 126648-126648
Open Access | Times Cited: 22
Peptide-Based Vaccines for Neurodegenerative Diseases: Recent Endeavors and Future Perspectives
Vyronia Vassilakopoulou, Chrysoula‐Evangelia Karachaliou, Alexandra Evangelou, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1278-1278
Open Access | Times Cited: 20
Critical thinking of Alzheimer’s transgenic mouse model: current research and future perspective
Xinyue Li, Meina Quan, Yiping Wei, et al.
Science China Life Sciences (2023) Vol. 66, Iss. 12, pp. 2711-2754
Open Access | Times Cited: 7
Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studies
Changyoun Kim, Armine Hovakimyan, Karen Zagorski, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 11
Passive Anti-Amyloid Beta Immunotherapies in Alzheimer’s Disease: From Mechanisms to Therapeutic Impact
Thomas Gabriel Schreiner, Cristina Croitoru, Diana Nicoleta Hodorog, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 1096-1096
Open Access | Times Cited: 2
The role of IL-1 family of cytokines in the pathogenesis and therapy of Alzheimer’s disease
ChangQing Li, Xun Zhang, Yunqian Wang, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 5, pp. 2681-2694
Closed Access | Times Cited: 2
Inflammation, Autoimmunity and Neurodegenerative Diseases, Therapeutics and Beyond
Jenny Garmendia, Claudia Valentina De Sanctis, Viswanath Das, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 6, pp. 1080-1109
Open Access | Times Cited: 6
Immunogenicity of MultiTEP platform technology-based Tau vaccine in non-human primates
Armine Hovakimyan, Karen Zagorski, Gor Chailyan, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 8
DNA with zwitterionic and negatively charged phosphate modifications: Formation of DNA triplexes, duplexes and cell uptake studies
Yongdong Su, Maitsetseg Bayarjargal, Tracy K. Hale, et al.
Beilstein Journal of Organic Chemistry (2021) Vol. 17, pp. 749-761
Open Access | Times Cited: 11
DNA Aβ42 immunization via needle-less Jet injection in mice and rabbits as potential immunotherapy for Alzheimer's disease
Doris Lambracht‐Washington, Min Fu, Mary Wight‐Carter, et al.
Journal of the Neurological Sciences (2023) Vol. 446, pp. 120564-120564
Closed Access | Times Cited: 4
Novel Vaccine against Pathological Pyroglutamate-Modified Amyloid Beta for Prevention of Alzheimer’s Disease
Karen Zagorski, Olga King, Armine Hovakimyan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9797-9797
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top